Track topics on Twitter Track topics that are important to you
BioDiem has acquired its initial products from leading Russian medical research institutes. This alliance has provided BioDiem with access to research projects with advanced data, in three cases with clinical studies showing promising results. To effectively manage development costs, BioDiem out-sources its research and development requirements to appropriate institutional centres of excellence and contract research organisations in Australia and overseas.
Level 10, South Tower459 Collins Street
Phone: 61 3 9613 4100
Fax: 61 3 9613 4111
Julie Phillips, Executive Director of BioDiem, discusses the work of their subsidiary company Opal Biosciences, who are developing a small molecule anti-microbial compound for drug-resistant infection...
SummaryBioDiem Ltd BioDiem is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates fo...
BioDiem has acquired its initial products from leading Russian medical research institutes. This alliance has provided BioDiem with access to research projects with advanced data, in three cases with ...
We have published hundreds of BioDiem Ltd news stories on BioPortfolio along with dozens of BioDiem Ltd Clinical Trials and PubMed Articles about BioDiem Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioDiem Ltd Companies in our database. You can also find out about relevant BioDiem Ltd Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...